期刊文献+

硫酸镁、盐酸拉贝洛尔配合生活调治法治疗妊高征患者的临床应用价值 被引量:14

Clinical application value of magnesium sulfate, labetalol hydrochloride combined with life-adjusting therapy in the treatment of the patients with pregnancy-induced hypertension
暂未订购
导出
摘要 目的研究硫酸镁、盐酸拉贝洛尔配合生活调治法治疗妊高征患者的临床应用价值。方法选取2016年8月~2017年8月妊高征患者90例作为本研究选取对象,电脑随机分为观察组与对照组,各45例,分别实施硫酸镁、盐酸拉贝洛尔配合生活调治法治疗以及常规治疗。结果观察组妊高征患者平均动脉压(112.02±1.02)mmHg、24 h尿蛋白(1.08±0.25)g相比对照组更具有优势(P<0.05)。观察组妊高征患者自然分娩率为97.78%,显著高于对照组,两组间相比较,差异有统计学意义(P<0.05)。观察组妊高征患者并发症发生概率为2.22%,低于对照组(P<0.05)。结论妊高征患者采用硫酸镁、盐酸拉贝洛尔配合生活调治法治疗效果十分显著,能够使其平均动脉压显著下降,改善妊娠结局,使其并发症发生率显著下降,值得临床推广应用。 Objective To study the clinical application value of magnesium sulfate, labetalol hydrochloride combined with life-adjustment therapy in the treatment of patients with pregnancy-induced hypertension. Methods A total of 90 patients with pregnancy-induced hypertension were selected as the study subjects in this study. The collection time was from August 2016 to August 2017. The patients were randomly divided into the observation group(45 patients with pregnancy-induced hypertension) and the control group(45 patients with pregnancy-induced hypertension) by computer randomization. Magnesium sulfate, labetalol hydrochloride combined with life-adjustment therapy and conventional treatment were performed respectively. Results The mean arterial pressure(112.02±1.02) mmHg and 24-hour urine protein (1.08±0.25)g in the observation group were more favorable than those in the control group(P〈0.05).The natural delivery rate of patients with pregnancy-induced hypertension in the observation group was 97.78%, which was significantly higher than that in the control group, and the difference between the two groups was significant(P〈0.05). The incidence rate of complications in the observation group was 2.22%, which was lower than that in the control group(P〈0.05). Conclusion The efficacy of magnesium sulfate and labetalol hydrochloride combined with life-adjusting therapy for the patients with pregnancy-induced hypertensionis is significant. It can significantly reduce the mean arterial pressure, improve the pregnancy outcome, and significantly reduce the incidence rate of complications, which is worthy of clinical application.
作者 傅小青 孙健 FU Xiaoqing;SUN Jian(Department of Obstetrics,Kaizhou District People's Hospital,Chongqing 405400,China;Department of Orthopedics,Kaizhou District People's Hospital,Chongqing 405400,China)
出处 《中国现代医生》 2018年第28期63-65,共3页 China Modern Doctor
关键词 妊高征 硫酸镁 盐酸拉贝洛尔 生活调治法 Pregnancy-induced hypertension Magnesium sulfate Labetalol hydrochloride Life-adjustment therapy
  • 相关文献

参考文献14

二级参考文献83

  • 1王九丽,秦小娟.硫酸镁及硫酸镁联合硝苯地平治疗妊高症84例疗效比较[J].航空航天医药,2011,22(1):89-90. 被引量:134
  • 2于科,项永兵.食物频率问卷的信度和效度研究进展[J].中国慢性病预防与控制,2006,14(2):136-139. 被引量:16
  • 3彭波.联合用药治疗妊高症136例临床疗效观察[J].地方病通报,2006,21(6):113-113. 被引量:9
  • 4曹泽毅.妇产科学[M].北京:人民卫生出版社,2010:82-87.
  • 5Mackay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preclampsia and eclampsia. Obstet Gynecol, 2001,97 : 533- 538.
  • 6Balderas-Pena LM, Canales-Munoz JL, Angulo-Vazquez J, et al. The HELLP syndrome-evidence of a possible systemic inflananatory response in pre-eclampsia? Ginecol Obstet Mex, 2002,70 : 328 -337.
  • 7Sibai B, Dekker G, Kupferminc M. Pre-eclampsis. Lancet, 2005,365:785-799.
  • 8Mackay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preclampsia and eclampsia. Obstet Gynecol, 2001,97: 533- 538.
  • 9彭波.联合用药治疗妊高症136例临床疗[J].效观地方病通报,2006,21(6):113.
  • 10程丽,陈梅.硫酸镁及硫酸镁联合硝苯地平治疗妊高症的临床观察[J].延边医学,2012(3):254-256.

共引文献455

同被引文献87

引证文献14

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部